← All organizations
Highest phase reached
Phase 3
Timeline
2010s
- Jan 9, 2015
sodium fluoride (18F)— Marketing Organization
Drugs by trial phase (1 distinct, 1 trials)
Phase 3 (1 own, 0 via acquisition)
Indications
Marketed drugs (3)
Recent trials (2)
- NCT01726088Lead sponsorPhase 2/Phase 3Aug 1, 2012
- NCT01726088Reponsible party - principal investigatorPhase 2/Phase 3Aug 1, 2012
Details
- Last known activity
- May 1, 2015